Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation-Reference-Cited by-同舟云学术

Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation

Published:2022-12-30 Issue:7 Volume:12 Page:8464-8475
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Naito Miki¹²^ORCID,Ikeda Kenichiro²,Aoyama Shunya¹,Kanamoto Mayu¹,Akasaka Yasuyuki¹²,Kido Yuri¹,Nakanishi Mikako¹,Kanna Machi¹,Yamamotoya Takeshi¹,Matsubara Akio²³,Hinata Nobuyuki²^ORCID,Asano Tomoichiro¹,Nakatsu Yusuke¹^ORCID

Affiliation:

1. Department of Medical Chemistry, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Hiroshima Japan

2. Department of Urology, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Hiroshima Japan

3. Department of Urology Hiroshima General Hospital Hatsukaichi Hiroshima Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5587

Reference43 articles.

1. Cancer statistics, 2020

2. Prostate cancer

3. Epidemiology of Prostate Cancer

4. Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

5. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities;Biology;2023-07-14